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Background: Intracranial hemorrhage (ICH) in full-term infants is uncommon and is 
a rare cause of neonatal fever. This study was conducted to estimate the incidences 
of ICH and fever in a hospital-based population, and to determine if the clinical 
features of neonatal ICH with and without hyperthermia differ.
Methods: We selected 315 afebrile neonates who received cranial ultrasonography 
screening from 2003 to 2004 as the control group, and 153 neonates diagnosed with 
fever from 1998 to 2004 as the study group. During the same period, 28 full-term 
neonates with birth weights > 2500 g and ICH in the first week of life were enrolled 
retrospectively. They were divided into hyperthermia (n = 11) and nonhyperthermia 
(n = 17) groups.
Results: Three babies in the control group and 11 in the study group had ICH; the 
incidence of ICH in the hyperthermia group was significantly higher (3/315 vs. 
11/153; p < 0.001). Compared with the nonhyperthermia group, the hyperthermia 
group had less cyanosis (2/11 vs. 10/17; p = 0.04), less lymphocyte predominance 
(33.7 vs. 80%; p = 0.032), higher neutrophil/lymphocyte ratio (1.9 vs. 0.3; p = 0.006), 
higher erythrocyte/leukocyte ratio (425 vs. 79.5; p = 0.05) in cerebrospinal fluid and 
an increased incidence of subarachnoid hemorrhage accompanied by intracerebral 
parenchymal hemorrhage (4/11 vs. 0/17; p = 0.016).
Conclusion: The incidence of ICH was higher in febrile than in afebrile neonates. 
ICH presenting with hyperthermia might go unrecognized, because its other symp-
toms are subtle and a neutrophil predominance in the cerebrospinal fluid might 
result in a misdiagnosis of meningitis. ICH in the interior brain tended to manifest 
more commonly as hyperthermia than did ICH in the superficial brain. A cranial 
image examination should be considered in the evaluation of neonatal fever.
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In many hospitals, febrile newborns are evaluated 
for sepsis and receive empirical antibiotics before 
the results of cultures are available.1 Intracranial 
hemorrhage (ICH) in full-term infants without low 
birth weight is uncommon and is seldom regarded 
as the cause of neonatal fever. ICH may manifest 
as hyperthermia, without other obvious neurologic 
symptoms or signs. However, it has rarely been re-
ported and the mechanism remains obscure. Thus, 
we retrospectively examined the medical charts of 
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full-term neonates with ICH and hyperthermia over 
a period of 7 years and analyzed their clinical fea-
tures. The goals of this study were: (1) to estimate 
the incidence of ICH among full-term neo nates 
younger than 1 week old; (2) to compare the dif-
ferences in clinical features between neonates with 
ICH presenting with or without hyperthermia; and 
(3) to seek a reasonable explanation for the differ-
ences between the two groups. We also reviewed 
the literature regarding the possible mechanisms 
for ICH-related hyperthermia and compared the 
differences between neonates and adult patients.
2. Methods
A total of 28,216 neonates were born in our insti-
tution from January 1998 to December 2004. After 
excluding 1675 preterm babies (gestational age < 37 
weeks) and 401 full-term babies with low birth 
weight (LBW; defined as < 2500 g), a total of 26,140 
living full-term babies were enrolled in the study. 
By searching the neonatal discharge diagnoses in our 
in-patient computer system, 28 neonates were found 
to have developed ICH within the first week of life. 
The medical records of these 28 neonates were 
retrospectively reviewed and analyzed. Twenty-five 
of the 28 babies had clinical manifestations during 
their stay in our nursery and were admitted to our 
neonatal observation room. Three babies were re-
admitted after discharge from our nursery because 
of severe jaundice in two babies and hypothermia in 
another. All cases of ICH were confirmed by cranial 
ultrasonography and computed tomography; dif-
ferent locations of ICH were identified, including 
epidural hemorrhage (EDH), subdural hemorrhage 
(SDH), subarachnoid hemorrhage (SAH), intracere-
bral parenchymal hemorrhage (IPH; hemorrhage in 
the brain parenchyma but not including intraven-
tricular hemorrhage), and intraventricular hemor-
rhage (IVH; hemorrhage only inside the ventricles 
with no spread into brain parenchyma).
Meanwhile, we selected 315 afebrile neonates 
younger than 1 week old, who received self-paid cra-
nial ultrasonography screening from 2003 to 2004, 
as the control group. Three of these developed ICH. 
During the period from 1998 to 2004, 153 full-term 
neonates without LBW were hospitalized for post-
partum neonatal fever. Hyperthermia or fever was 
defined as a rectal temperature ≥ 38°C. We excluded 
infants with confirmed infections, those with major 
congenital malformations, and infants who or whose 
mothers had received particular medical treatments 
that might interfere with the babies’ temperatures 
(maternal or infant antibiotic therapy, blood trans-
fusion or exchange transfusion) before or during the 
onset of fever. The 28 infants were divided into two 
groups according to the highest rectal temperature 
recorded after birth and prior to admission: hyper-
thermia group (rectal temperature ≥ 38°C) and non-
hyperthermia group (rectal temperature < 38°C). 
Clinical features and laboratory data for the two 
groups were compared, including gender, gestational 
age, birth weight, delivery method (normal vaginal 
delivery, vacuum delivery, cesarean section), Apgar 
scores, initial clinical presentations, laboratory data 
(complete blood cell counts, differential white cell 
counts, prothrombin time, activated partial throm-
boplastin time, blood sugar, cerebrospinal fluid [CSF] 
routine studies), the number of patients receiving 
phototherapy and their direct/total bilirubin levels, 
and cranial image findings (EDH, SDH, SAH, IPH, IVH, 
brain edema).
Descriptive data were reported as median (inter-
quartile range). The Mann-Whitney test was used to 
analyze continuous variables, while Chi-square or 
Fisher’s exact tests were used for categorical vari-
ables. A p value < 0.05 was considered statistically 
significant. The data were analyzed using SPSS 11.0 
(SPSS Inc., Chicago, IL, USA) statistical software.
3. Results
The estimated incidence of postpartum fever in 
our hospital was 0.6% (153/26,140 live births). The 
estimated local incidence of ICH among full-term 
neonates without LBW was at least 0.11% (28/26,140 
live births), although we could not undertake cranial 
imaging in all neonates. The approximate incidence 
of ICH among those afebrile neonates in the control 
group was 0.95% (3/315 live births; one EDH and 
two SDH, confirmed by computed tomography scan). 
Among 153 neonates with fever, 11 babies (7.2%) 
had ICH, and this incidence was significantly higher 
than that in afebrile neonates (11/153 vs. 3/315; 
p < 0.001). Fifteen babies (9.8%) had culture-proven 
bacterial infections, including one baby (0.7%) who 
had Coxsackie B virus cultured from the CSF. No 
definite etiology for the hyperthermia was con-
firmed in the remaining 126 babies (82%).
Among the 28 neonates with ICH, 11 infants 
(39.3%) developed hyperthermia as an early man-
ifestation during the initial 4 days after birth. 
Comparing the hyperthermia group and the nonhy-
perthermia group, no significant differences existed 
in gender, birth weights, gestational ages, delivery 
methods, Apgar scores or initial clinical presen-
tations (Table 1), laboratory data or the number of 
patients whose bilirubin levels met the criteria for 
phototherapy (Table 2). However, in terms of clini-
cal presentation, the hyperthermia group demon-
strated less cyanosis than the nonhyperthermia group 
(2/11 vs. 10/17; p = 0.04). In the CSF study, these 
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cases had less lymphocyte predominance (33.7% 
vs. 80%; p = 0.032), a higher neutrophil/lymphocyte 
ratio (1.9 vs. 0.3; p = 0.006), and a higher erythro-
cyte/leukocyte ratio (425 vs. 79.5; p = 0.05, trend 
level). Seizures eventually developed in one case 
of the hyperthermia group and in four of the non-
hyperthermia group during their entire hospitali-
zation, but only one case in the latter group had 
seizure as the initial manifestation (Table 1). The 
electroencephalograms were normal in all patients. 
Also, there were no differences in the incidences of 
EDH, SDH, SAH, or brain edema between the two 
groups. However, SAH accompanied by IPH (4/11 
vs. 0/17; p = 0.016) and IVH (3/11 vs. 0/17; p = 0.05, 
trend level) occurred more often in the hyperthermia 
group than in the nonhyperthermia group (Table 3). 
ICH in all 28 patients improved within 1 week, as 
seen by sonography. Clinical outcomes in all patients 
were good, with no obvious sequelae.
4. Discussion
Fever, defined as an axillary or rectal temperature 
≥ 37.8°C, has been reported to occur in 1% of full-
term newborns in the normal nursery.2 In our study, 
the incidence of postpartum neonatal fever was 
0.6%, lower than the previous report. This discrep-
ancy is probably due to a stricter definition of fever 
or loss to follow-up for some babies after discharge 
from nursery. Documented bacterial diseases have 
been reported in 10−14.5% of febrile newborns2,3 
and 9.6% of febrile infants < 8 weeks old.4 Our se-
ries showed a similar incidence (10.6%). However, 
there are several etiologies for fever in low-risk 
full-term infants during the initial postpartum days. 
Postpartum fever with no other symptoms is pri-
marily related to dehydration, insufficient breast-
feeding, cesarean section, and high birth weight.5 
The estimated local incidence of symptomatic ICH 
for the inborn population was 4.9/10,000 live births, 
with a regional incidence of 2.7/10,000 live births.6 
The incidence of symptomatic IVH in full-term in-
fants has been reported to range from 3.6/10,000 
to 6.6/10,000 live births.7,8 Although not every ne-
onate underwent a cranial image examination and 
the actual incidence of ICH could, therefore, not be 
obtained, a higher incidence of ICH (at least 11/
10,000 live births) was observed in our study. Fur-
ther, the incidence of ICH was significantly higher 
among febrile full-term neonates than in afebrile 
neonates (7.2% vs. 0.95%) in our study. This finding 
suggests that previous reports of ICH may have un-
derestimated its incidence. However, the percentage 
of full-term neonates without LBW, who presented 
with hyperthermia as an early sign of ICH, was as 
high as 25% (7/28), which emphasized the clinical 
significance of such a presentation. Another report 
Table 1 Clinical features of intracranial hemorrhage patients with and without hyperthermia
Variable Hyperthermia group (n = 11) Nonhyperthermia group (n = 17) p
Male babies, n (%) 6 (54.5) 11 (64.7) 0.825
Admission age (d) 0.7 (0.1−2.8) 0.9 (0−2) 0.866
Gestational age (wk) 38.8 (36.8−39.9) 39 (36.5−40) 0.847
Birth weight (g) 3370 (2975−3433.3) 3040 (2825−3380) 0.323
Delivery method, n
 Normal vaginal delivery 6  4 0.103
 Vacuum delivery 4  6 0.679
 Cesarean section 1  6 0.131
Apgar score at 1 minute 9 (8.5−9) 9 (9−9) 0.34
Apgar score at 5 minute 10 (10−10) 10 (10−10) 0.642
Onset of fever (d) 1.7 (0.3−2.9) − −
Initial presentation, n
 Fever 7  0 0.0003*
 Cyanosis 2 10 0.04*
 Hypothermia 1  0 0.393
 Jaundice 1  2 0.664
 Seizure 0  1 0.607
 Depressed skull fracture 0  1 0.607
 Screened by sonography 0  3 0.208
Data are expressed as median (interquartile range). *Statistically significant by Fisher’s exact test.
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Table 2 Laboratory data for intracranial hemorrhage patients with and without hyperthermia*
Variable Hyperthermia group (n = 11)  Nonhyperthermia group (n = 17) p
Hemoglobin (g/dL) 15.2 (14.4−16.3) 16.1 (13.9−16.9) 0.384
Hematocrit (%) 44.7 (41.8−47.5) 47.9 (39.9−49.5) 0.438
Leukocyte count (/mm3) 14,900 (12,000−18,025) 13,200 (10,400−22,450) 0.778
 Lymphocytes (%) 32 (26−47) 26 (21−31) 0.132
 Monocytes (%) 5 (4−8) 8 (6−10) 0.135
 Neutrophils (%) 53 (45−63) 62 (46−68) 0.41
 Band forms (%) 0 (0−1) 0 (0−4) 0.389
 (L + M)/(N + B) 0.75 (0.53−1.18) 0.43 (0.39−0.95) 0.213
Platelets (× 103/mm3) 268 (197.5−305.5) 241 (215.5−279.5) 0.707
Prothrombin time (s) 10.7 (10.4−16) 13.3 (13.2−18.7) 0.399
aPTT (s) 45.3 (35.4−73.9) 44.3 (35.3−53.4) 0.635
Blood glucose (mg/dL) 69 (60.5−75.3) 73 (60.8−96.3) 0.525
CSF routine
 Erythrocytes (/mm3) 13,928 (811.3−101,000) 1166 (52.5−95,750) 0.369
 Leukocytes (/mm3) 44 (1.8−310) 13.5 (5.8−525) 0.935
 Lymphocytes (%) 33.7 (22.8−57.5) 80 (49.3−100) 0.032†
 Neutrophils (%) 60.3 (19.1−70.5) 20 (0−50.5) 0.146
 Neutrophil/lymphocyte 1.9 (0−2.6) 0.3 (0.1−1.2) 0.006†
  ratio
 Erythrocyte/leukocyte ratio 425 (18.6−1371.3) 79.5 (7.3−199.1) 0.05‡
 Protein (mg/dL) 187 (138.8−219.3) 102 (58−200) 0.145
 Glucose (mg/dL) 49 (29.5−64.8) 49 (39−60) 0.965
Phototherapy for jaundice, n 5 4 0.212
 Direct bilirubin (mg/dL) 0.45 (0.4−0.5) 0.7 (0.5−0.7) 0.063
 Indirect bilirubin (mg/dL) 16.9 (12.2−20.8) 17 (14.4−26.8) 0.456
 Total bilirubin (mg/dL) 17.4 (12.8−20.2) 17.7 (15.1−27.3) 0.456
 Direct/total bilirubin (%) 2.87 (1.91−3.94) 4.6 (4−18.3) 0.101
*Data are expressed as median (interquartile range); †statistically significant by Mann-Whitney test; ‡trend level by Mann-Whitney 
test. L = lymphocytes; M = monocytes; N = neutrophils; B = band forms; aPTT = activated partial thromboplastin time; CSF = 
cerebrospinal fluid.
Table 3 Cranial image findings and intracranial hemorrhage locations
Variable Hyperthermia group (n = 11)  Nonhyperthermia group (n = 17) p
Cumulative case, n
 EDH 0 1 0.607
 SDH 6 8 0.5
 SAH 10 11 0.131
 IPH 4 4 0.877
 IVH 3 0 0.05†
 Brain edema 5 9 0.5
Individual case, n
 EDH only 0 1 0.607
 SDH only 0 3 0.208
 SAH only 1 6 0.131
 IPH only 0 2 0.36
 IVH only 1 0 0.393
 SDH + SAH 3 3 0.859
 SAH + IPH 4 0 0.016*
 SAH + IVH 2 0 0.146
 SDH + SAH + IPH 0 2 0.36
*Statistically significant by Fisher’s exact test; †trend level by Fisher’s exact test. EDH = epidural hemorrhage; SDH = subdural 
hemorrhage; SAH = subarachnoid hemorrhage; IPH = intracerebral parenchymal hemorrhage; IVH = intraventricular hemorrhage.
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also identified a high incidence (47%) of fever among 
36 full-term infants with IVH, although it did not 
mention whether fever was an initial sign or not.8
Compared with the high incidence of peri/in-
traventricular hemorrhage in immature neonates,9 
spontaneous ICH in full-term neonates without LBW 
is rare, after excluding the common etiologies such 
as coagulopathy, birth trauma, asphyxia or perina-
tal insult. In addition to central nervous system 
infections in which fever is quite common,10 ICH 
presenting with fever has been found in infants 
with cerebral venous thrombosis,11 vitamin K defi-
ciency,12,13 perinatal alloimmune thrombocytope-
nia,7,8 congenital brain tumor,14 arteriovenous 
malformation,15 prothrombin complex deficiency,16 
or unknown etiologies.17 In our study, the high inci-
dence of hyperthermia among the full-term neonates 
with ICH revealed a possible correlation between 
hyperthermia and ICH. We presumed that hypoxia 
in these neonates was mild, because relatively few 
babies with ICH and hyperthermia developed cya-
nosis. Nevertheless, the amount of bleeding in ICH 
might account for the development of hyperthermia, 
because more erythrocytes in proportion to leuko-
cytes leaked into the CSF in the hyperthermia group. 
Most neonates with fever have a lumbar puncture 
performed to diagnose meningitis, therefore some 
cases of IVH may be misinterpreted as a bloody tap. 
In addition, in some cases, the fever may be wrongly 
attributed to exogenous overheating. Therefore, IVH 
in febrile neonates may be underdiagnosed.18
A number of possible mechanisms for ICH-related 
hyperthermia have been documented, including: 
(1) the putative mechanism,19 (2) the lower midbrain 
mechanism,20 (3) the hemoglobin-enhanced pros-
taglandins (prostaglandin E2 [PGE2], prostaglandin 
F2α [PGF2α]) mechanism,21−23 and (4) the proin-
flammatory cytokines (interleukin-1, interleukin-6 
and tumor necrosis factor-α) mechanism.24,25 Cats 
with no blood reaching the ventral portion of the 
third ventricle, possibly the anterior hypothalamic 
and preoptic nuclei, did not become febrile even in 
the presence of massive clots in the other ventricles 
or in the cisternal spaces.19 In another experiment 
with rats, hyperthermia was caused by the removal 
of a tonic inhibitor mechanism of heat production 
that exists in the lower midbrain. Transection of the 
brain at the lower level removed the tonic inhibi-
tory mechanism and induced a release phenomenon, 
resulting in reinstatement of the thermoregulatory 
ability. Thus, it is presumed that the hyperthermia 
in patients with brainstem hemorrhage might be 
caused by disinhibition of heat production due to 
the release of such a lower midbrain mechanism.20 
Because hemoglobin has been shown to induce the 
production of PGE2 and PGF2α from arachidonic acid 
by enhancing cyclooxygenase capacity,23 and as 
these prostaglandins are considered to be the final 
mediators of the febrile response,22 a rabbit model 
of SAH demonstrated that a higher amount of he-
moglobin produced a significant increase in core 
temperature, accompanied by a significant increase 
of CSF PGE2.21 In previous studies of human patients 
with SAH, levels of proinflammatory cytokines in-
creased after SAH, and high levels of some cytokines 
correlated with brain damage.24,25
The outcomes of neonates with ICH presenting 
with hyperthermia in our study were better than 
those of adult patients26−29 and infants.7,8,18 It may 
be reasonable to hypothesize that the open ante-
rior fontanelles of neonates can relieve increased 
intracranial pressure, thereby reducing brain dam-
age, and so lead to a better outcome. Early diagnosis 
and prompt intervention for reducing intracranial 
pressure and controlling seizure might be another 
reason.18 There are some controversies regarding 
the factors predicting poor outcome in this condi-
tion. Fever developed in 41% of adult patients with 
SAH and was associated with vasospasm and poor 
outcome, independently of hemorrhage severity or 
presence of infection. Older age and intubation were 
also related to poor outcome.27 In another study of 
251 adult patients with spontaneous supratentorial 
ICH, the incidence of fever was as high as 42%, es-
pecially in patients with IVH. In patients surviving 
the first 72 hours after hospital admission, the du-
ration of fever was associated with poor outcome 
and seemed to be an independent prognostic fac-
tor in this group.28 However, another study of 152 
adult patients with supratentorial primary ICH con-
cluded that hyperthermia was not an independent 
predictor of greater mortality in patients with pri-
mary ICH.29 Patients with hyperthermia on the first 
day of hospitalization had greater 30-day mortality 
and worse functional status 30 days after stroke. 
Increased body temperature correlated significantly 
with the severity of neurologic deficit; however, it 
did not predict the overall mortality in multivariate 
analysis.29
In contrast to the high proportion (25%) of hyper-
thermia in neonates with ICH, the low incidence 
(7.2%) of ICH among full-term neonates with fever 
may represent an underestimate, because not every 
baby has neurologic symptoms/signs nor is a cra-
nial image examination routinely performed. How-
ever, the relatively high incidence of hyperthermia 
in neonates with ICH emphasizes the importance 
of fever as an initial sign. Among these babies, the 
predominance of neutrophils in proportion to lym-
phocytes in the CSF may lead clinicians to make a 
diagnosis of meningitis before the results of CSF 
cultures are confirmed. Similarly, the predomi-
nance of erythrocytes in proportion to leucocytes 
may be misinterpreted as a bloody tap, if there is 
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no cranial image study. ICH may be neglected and 
appropriate treatment delayed if the possibility of 
ICH is not considered early. Our observation that 
infants with ICH manifesting as hyperthermia had 
better outcomes than adult patients suggests that 
ICH in infants might be a milder or more subtle con-
dition than ICH in adults. Regardless of the patho-
genetic mechanisms of fever in ICH patients, our 
study points to the need to consider ICH in the dif-
ferential diagnosis of neonates with hyperthermia. 
This entity should be considered even in the ab-
sence of clear clinical or laboratory signs of ICH. 
When unknown fever persists in young infants after 
adequate hydration and after excluding other in-
fectious etiologies, a cranial image, preferably so-
nography first, should be considered, rather than 
antibiotic therapy alone.
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